Published on in Vol 11, No 2 (2022): Jul-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/40597, first published
.

Journals
- Fossouo Tagne J, Yakob R, Dang T, Mcdonald R, Wickramasinghe N. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review. JMIR Public Health and Surveillance 2023;9:e40080 View
- Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy. JMIR Human Factors 2023;10:e43529 View
- Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study. JMIR Formative Research 2023;7:e48976 View
- Naderian S, Rahmani R, Samad-Soltani T. A Natural Language Processing Framework for Detecting Adverse Drug Reactions in Clinical Structured Drug Reviews. International Journal of Drug Research in Clinics 2024;2:e9 View
- Xia X, Yang X, Du J, Cheng W, Chen X, Zhang W, Yin Z. Exploring willingness to use adverse drug reaction reporting systems: a multicentre qualitative study in China based on the technology acceptance model and task-technology fit integration approach. BMJ Open 2024;14(10):e087701 View
- Ishaqui A, Tripathi R, Rajpoot P, Bakhsh R, Thanganadar H, Aldomini M, Ahmad S, Orayj K, Kumar N, Khalil A, Kaddoura M, Maqsood M. Barriers to Adverse Drug Reaction Reporting Among Physicians, Nurses, and Pharmacists: A Scoping Review Comparing High-Income Versus Low-/Middle-Income Countries. Healthcare 2026;14(7):930 View
Books/Policy Documents
- Nguyen N. Technology Enhanced Learning for Inclusive and Equitable Quality Education. View
